Net Cash Provided by (Used in) Operating Activities |
-7.86K |
USD |
+68.6% |
Apr 30, 2024 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
2.36K |
USD |
-93.6% |
Apr 30, 2024 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
8.6K |
USD |
0% |
Apr 30, 2024 |
Q1 2023 |
Common Stock, Shares Authorized |
75M |
shares |
0% |
Apr 30, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
5.5M |
shares |
+4.07% |
Apr 30, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Apr 30, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
23.7K |
USD |
+15.1% |
Apr 30, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Apr 30, 2024 |
Q1 2023 |
Deferred Tax Assets, Valuation Allowance |
1.65K |
USD |
-69.9% |
Apr 30, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Oct 31, 2022 |
Q3 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.65K |
USD |
-69.9% |
Apr 30, 2024 |
Q1 2024 |
Additional Paid in Capital |
24.7K |
USD |
+9.43% |
Apr 30, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
2.15K |
USD |
0% |
Jul 31, 2023 |
Q2 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Apr 30, 2024 |
Q1 2024 |